Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Sep;83(3):371-83.
doi: 10.1007/s11126-012-9208-4.

Lamotrigine in the treatment of unipolar depression with and without comorbidities: a literature review

Affiliations
Review

Lamotrigine in the treatment of unipolar depression with and without comorbidities: a literature review

Adam Daniel Zavodnick et al. Psychiatr Q. 2012 Sep.

Abstract

To review the available data behind the use of lamotrigine in unipolar depression and common comorbid conditions. A PubMed based literature review was conducted using keywords related to lamotrigine, depression, anxiety, post traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and personality disorders. A large number of trials using lamotrigine for unipolar depression and various comorbid conditions were reviewed. A major limitation behind the majority of studies was a limited course of the treatment phase. The most robust data was found among studies that followed patients for over 8 weeks, and used higher dosages. Patients with comorbid anxiety states appeared to benefit. Patients with borderline personality disorder also appeared to benefit. The benefits of lamotrigine in unipolar depression have been inconsistently noted in a number of studies. This is due in part to short treatment phases, atypical domains of benefit and different patient populations across studies. Patients with more treatment-resistance, comorbid anxiety and borderline personality disorder may be more able to benefit from lamotrigine.

PubMed Disclaimer

References

    1. Bipolar Disord. 2001 Apr;3(2):58-62 - PubMed
    1. Int Clin Psychopharmacol. 2007 May;22(3):179-82 - PubMed
    1. Clin Neuropharmacol. 1998 Jan-Feb;21(1):41-7 - PubMed
    1. J Psychopharmacol. 2005 May;19(3):287-91 - PubMed
    1. MedGenMed. 2006 Aug 23;8(3):46 - PubMed

MeSH terms

LinkOut - more resources